Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Objective: to compare blood glucose and insulin responses after consumption of 100ml water, sweetened with 25gr ZustoĀ® and 100ml water sweetened with 25gr GlucomedicsĀ® (standard drink)
This is an experimental study enrolling 10 healthy female subjects. The study compares the blood glucose and insulin responses after consumption of 100ml water, sweetened with 25gr ZustoĀ® and 100ml water sweetened with 25gr GlucomedicsĀ® (standard drink). Subjects need to be fasted for at least 8 hours before all visits. At visit 1, five women will consume the solution with 25gr ZustoĀ®, the other five will have the solution with 25gr GlucomedicsĀ®. On visit 2, groups will be switched. Visit 1 and 2 will be performed within approximately one week interval.
Both drinks will be identical in amount of water and only be different by the use of 25gr GlucomedicsĀ® and 25gr ZustoĀ®.
Before intake of the drink, vital signs, weight and bedside blood glucose and baseline blood samples - 15' and 0' for glucose, insulin and C-peptide will be taken at visit 1 and 2. Both drinks will be consumed within 5 minutes and time of start and end of intake of ZustoĀ® / GlucomedicsĀ® will be documented.
Blood samples for glucose, insulin and C-peptide will be taken at 15', 30', 60', 90', 120' and 180' after start of intake 25gr ZustoĀ® and 25gr GlucomedicsĀ®.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| GlucomedicsĀ® | Active Comparator | 25gr GlucomedicsĀ® |
|
| ZustoĀ® | Experimental | 25gr ZustoĀ® |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Zusto | Dietary Supplement | 25gr |
| |
| GlucomedicsĀ® |
| Measure | Description | Time Frame |
|---|---|---|
| the difference in glycemic index between 25gr. ZustoĀ® and 25gr. GlucomedicsĀ® | GI values will be calculated using the iAUC of ZustoĀ® intake and GlucomedicsĀ® intake. | 1 month |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bart Keymeulen, MD PhD | Universitair Ziekenhuis Brussel | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29460783 | Derived | Pen JJ, Khorosheva G, Van de Velde U, Debroye C, Huyghebaert A, Rottiers R, Keymeulen B. Zusto: A new sweetening agent with low glycemic index. Clin Nutr ESPEN. 2018 Feb;23:103-106. doi: 10.1016/j.clnesp.2017.11.009. Epub 2017 Dec 7. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dietary Supplement |
25gr |
|